After treatment with moroidin, the levels of mesenchymal state markers, including N-cadherin, vimentin, SNAIL, and TWIST, decreased in a dose-dependent manner, while E-cadherin expression level was increased, demonstrating that moroidin inhibited EMT in GBM cells. Here, CDH2 is linked to glioblastoma.